GENETRONICS WKN 903221 !!!

GENETRONICS WKN 903221 !!!, Genetronics Announces Successful Introduction of MedPulser? Electroporation Therapy System at European Oral Cancer Conference May 7, 2001 8:01am SAN DIEGO, and THE HAGUE, The Netherlands, May 7 /CNW/ -- Genetronics Biomedical Ltd. (Amex: GEB; Toronto) today announced the successful introduction of the MedPulser Electroporation Therapy System (EPT) while presenting at the Seventh International Congress on Oral Cancer (ICOOC) in the Netherlands. As part of the Company's European Access Program (EAP), several surgeons in Europe have reported successful experiences with the MedPulser? system for head and neck cancer treatments. For instance, Dr. Thomas Plath of the Benjamin Franklin Medical Center (Berlin, Germany) described one of his recent patient cases involving a tumor in the tongue. One day after electroporation therapy, there was some crusting of the patient's tumor and a decrease in pain, said Dr. Plath. Thirteen days after electroporatio [mehr]

aktiencheck.de - Forum - Genetronics Biomedical

GENETRONICS WKN 903221 !!!